Isa Pharmaceuticals – Immune System Activation
  • nl
  • fr
  • de
  • Home
  • Company
    • Company Milestones
    • Strategy
    • Management
    • Supervisory Board
    • Advisory Board
  • Pipeline
    • Pipeline Chart
    • Pipeline Overview
  • Clinical Studies
  • Technology
    • SLP® Concept
    • Publications
    • Technology Overview
  • News & Events
    • News Archive
    • Upcoming Events
  • Job Openings
  • Contact
    • Imprint / Disclaimer

Immunotherapeutics against cancer and infectious diseases

ISA Pharmaceuticals B.V. is developing rationally designed, fully synthetic immunotherapeutics against cancer and persistent viral infections.

Read more

News

  • May 23, 2018

    ISA Pharmaceuticals Promotes Gerben Moolhuizen to Chief Executive Officer

  • April 30, 2018

    ISA Pharmaceuticals Appoints Leon Hooftman as Chief Medical Officer

Events

    Latest Publications

    • September 5, 2016
      Cancer Research / Science Translational Medicine

      Cancer Research / Science Translational Medicine

    More news
    More events
    More publications
    Loading Quotes...
    © ISA Pharmaceuticals B.V. all rights reserved
    • Contact
    • Sitemap
    • Imprint / Disclaimer